{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:16:48Z","timestamp":1767676608120,"version":"3.40.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T00:00:00Z","timestamp":1361404800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s11096-013-9755-2","type":"journal-article","created":{"date-parts":[[2013,2,20]],"date-time":"2013-02-20T06:20:26Z","timestamp":1361341226000},"page":"425-431","source":"Crossref","is-referenced-by-count":13,"title":["Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian Regulatory Agency versus FDA"],"prefix":"10.1007","volume":"35","author":[{"given":"Anna Paula de S\u00e1","family":"Borges","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00edlia Silveira de Almeida","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo R\u00e9gis Leira","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,21]]},"reference":[{"key":"9755_CR1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00228-007-0390-5","volume":"64","author":"K Hoppu","year":"2008","unstructured":"Hoppu K. Paediatric clinical pharmacology\u2014at the beginning of a new era. Eur J Clin Pharmacol. 2008;64:201\u20135.","journal-title":"Eur J Clin Pharmacol"},{"key":"9755_CR2","unstructured":"World Health Organization. Promoting safety of medicines for children. Geneva: WHO; 2007. ISBN 978-92-4-156343-7."},{"key":"9755_CR3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1542\/peds.104.S3.585","volume":"104","author":"JT Wilson","year":"1999","unstructured":"Wilson JT. An update on the therapeutic orphan. Pediatrics. 1999;104:585\u201390.","journal-title":"Pediatrics"},{"key":"9755_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002018-200225010-00001","volume":"25","author":"I Choonara","year":"2002","unstructured":"Choonara I, Conroy S. Unlicensed and off-label drug use in children\u2014implications for safety. Drug Saf. 2002;25:1\u20135.","journal-title":"Drug Saf"},{"key":"9755_CR5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00128072-200204060-00002","volume":"4","author":"S Conroy","year":"2002","unstructured":"Conroy S. Unlicensed and off-label drug use\u2014issues and recommendations. Paediatr Drugs. 2002;4:353\u20139.","journal-title":"Paediatr Drugs"},{"key":"9755_CR6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2710.2002.00429.x","volume":"27","author":"Y Hanssens","year":"2002","unstructured":"Hanssens Y, Deleu D, Al Balushi K, Al Hashar A, Al-Zakwani I. Drug utilization pattern of anti-epileptic drugs: a pharmacoepidemiologic study in Oman. J Clin Pharm Ther. 2002;27:357\u201364.","journal-title":"J Clin Pharm Ther"},{"key":"9755_CR7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.2042-7174.2011.00156.x","volume":"20","author":"S Koshy","year":"2012","unstructured":"Koshy S. Role of pharmacists in the management of patients with epilepsy. Int J Pharm Pract. 2012;20:65\u20138.","journal-title":"Int J Pharm Pract"},{"key":"9755_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1651-2227.2012.02656.x","volume":"101","author":"E Kimland","year":"2012","unstructured":"Kimland E, Nydert P, Odlind V, B\u00f6ttiger Y, Lindemalm S. Pediatric drug use with focus on off-label prescriptions at Swedish hospital\u2014a nationwide study. Acta Paediatr. 2012;101:1\u20137.","journal-title":"Acta Paediatr"},{"key":"9755_CR9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00228-009-0747-z","volume":"66","author":"C Morales-Carpi","year":"2010","unstructured":"Morales-Carpi C, Esta\u00f1 L, Rubio E, Lurbe E, Morales-Olivas FJ. Drug utilization and off-label drug use among Spanish emergency room pediatric patients. Eur J Clin Pharmacol. 2010;66:315\u201320.","journal-title":"Eur J Clin Pharmacol"},{"key":"9755_CR10","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/adc.87.6.462","volume":"87","author":"A Clarkson","year":"2002","unstructured":"Clarkson A, Choonara I. Surveillance for fatal suspected adverse drug reaction in the UK. Arch Dis Child. 2002;87:462\u20137.","journal-title":"Arch Dis Child"},{"key":"9755_CR11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.pcl.2005.09.010","volume":"53","author":"DOMJ Friedman","year":"2006","unstructured":"Friedman DOMJ, Sharieff MDGQ. Seizures in children. Pediatr Clin N Am. 2006;53:257\u201377.","journal-title":"Pediatr Clin N Am"},{"key":"9755_CR12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2710.2000.00271.x","volume":"25","author":"LC Chen","year":"2000","unstructured":"Chen LC, Chen YF, Yang LL, Chou MH, Lin MF. Drug utilization pattern of antiepileptic drugs and traditional Chinese medicines in a general hospital in Taiwan\u2014a pharmaco-epidemiologic study. J Clin Pharm Ther. 2000;25:125\u20139.","journal-title":"J Clin Pharm Ther"},{"key":"9755_CR13","unstructured":"Food and Drug Administration. Guidance for industry: E11 clinical investigation of medicinal products in the pediatric population. Rockille, Md. 2000. Available: http:\/\/www.fda.gov\/downloads\/RegulatoryInformation\/Guidances\/ucm129477.pdf . Accessed 30 Aug 2012."},{"key":"9755_CR14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/bmj.316.7128.343","volume":"316","author":"S Turner","year":"1998","unstructured":"Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ. 1998;316:343\u20135.","journal-title":"BMJ"},{"key":"9755_CR15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.33588\/rn.4608.2008020","volume":"46","author":"E Abasolo-Osinaga","year":"2008","unstructured":"Abasolo-Osinaga E, Abecia-Inchaurregui LC, Etxeandia-Ikobaltzeta I, Burgos-Alonso N, Pozo JG. Estudio farmacoepidemiol\u00f3gico del consumo de f\u00e1rmacos antiepil\u00e9pticos (1992\u20132004). Rev Neurol. 2008;46:449\u201353.","journal-title":"Rev Neurol"},{"key":"9755_CR16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.yapd.2011.03.001","volume":"58","author":"AH Chen","year":"2011","unstructured":"Chen AH. Update on pediatric epilepsy. Adv Pediatr. 2011;58:259\u201376.","journal-title":"Adv Pediatr"},{"key":"9755_CR17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.amjmed.2009.11.013","volume":"51","author":"SS Hasan","year":"2010","unstructured":"Hasan SS, Bahari MB, Bazar ZU, Ganesan V. Antiepileptic drug utilization and seizure outcome among pediatric patients in a Malaysian public hospital. Singap Med J. 2010;51:21\u20137.","journal-title":"Singap Med J"},{"key":"9755_CR18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2710.1997.tb00012.x","volume":"22","author":"CLP Deckers","year":"1997","unstructured":"Deckers CLP, Hekstert YA, Keyser A, Meinardi H, Reiner WO. Pharmacotherapy of epilepsy: state of the art and developments. J Clin Pharm Ther. 1997;22:309\u201322.","journal-title":"J Clin Pharm Ther"},{"key":"9755_CR19","unstructured":"Minist\u00e9rio da Sa\u00fade (Brazil). PORTARIA SAS\/MS No 492, de 23 de setembro de 2010. Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas\u2014Epilepsia. [Brazilian Therapeutic Guideline\u2014Epilepsy]. Available: http:\/\/portal.saude.gov.br\/portal\/arquivos\/pdf\/pcdt_epilepsia_.pdf . Accessed 05 April 2012."},{"key":"9755_CR20","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1528-1167.2006.00585.x","volume":"47","author":"T Glauser","year":"2006","unstructured":"Glauser T, Ben-Menachem E, Borgeous B, Cnaan A, Chadwick D, Guerreiro C, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006;47:1094\u2013120.","journal-title":"Epilepsia"},{"key":"9755_CR21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.spen.2010.06.005","volume":"17","author":"NS Abend","year":"2010","unstructured":"Abend NS, Gutierrez-Colina AM, Dlugos DJ. Medical treatment of pediatric status epileptics. Semin Pediatr Neurol. 2010;17:169\u201375.","journal-title":"Semin Pediatr Neurol"},{"issue":"5","key":"9755_CR22","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","volume":"342","author":"P Kwan","year":"2000","unstructured":"Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342(5):314\u20139.","journal-title":"N Engl J Med"},{"issue":"6","key":"9755_CR23","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.seizure.2012.04.014","volume":"21","author":"JM Nicholas","year":"2012","unstructured":"Nicholas JM, Ridsdale L, Richardson MP, Ashworth M, Gulliford MC. Trends in antiepileptic drug utilisation in UK primary care 1993\u20132008: cohort study using the general practice research database. Seizure. 2012;21(6):466\u201370.","journal-title":"Seizure"},{"key":"9755_CR24","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2125.2005.02529.x","volume":"61","author":"E Perucca","year":"2005","unstructured":"Perucca E. Clinically relevant drug interaction with antiepileptic drugs. Br J Clin Pharmacol. 2005;61:246\u201355.","journal-title":"Br J Clin Pharmacol"},{"key":"9755_CR25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2174\/157015910792246254","volume":"8","author":"SI Johannessen","year":"2010","unstructured":"Johannessen SI, Landmark CJ. Antiepileptic drug interactions\u2014principles and clinical implications. Curr Neuropharmacol. 2010;8:254\u201367.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"9755_CR26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11096-011-9590-2","volume":"34","author":"ZM Yi","year":"2012","unstructured":"Yi ZM, Zhai SD, Huang S, Wang TS, Liu F. Off-label prescriptions for adult neurological patients: a pilot survey in China. Int J Clin Pharm. 2012;34(1):81\u20137.","journal-title":"Int J Clin Pharm"},{"issue":"320","key":"9755_CR27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/bmj.320.7227.79","volume":"7227","author":"S Conroy","year":"2000","unstructured":"Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, et al. Survey of unlicensed and off-label drug use in paediatric wards in European countries. BMJ. 2000;7227(320):79\u201382.","journal-title":"BMJ"},{"key":"9755_CR28","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archpedi.161.3.282","volume":"161","author":"SS Shah","year":"2007","unstructured":"Shah SS, Goodman D, Feur P, Sharma V, Fargason C Jr, Hyman D, et al. Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med. 2007;161:282\u201390.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"9755_CR29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11096-006-9081-z","volume":"29","author":"M Dell\u2019Aera","year":"2007","unstructured":"Dell\u2019Aera M, Gasbarro AR, Padovano M, Laforgia N, Capodiferro D, Solarino B, et al. Unlicensed and off-label use of medicines at a neonatology clinic in Italy. Pharm World Sci. 2007;29(4):361\u20137.","journal-title":"Pharm World Sci"},{"key":"9755_CR30","first-page":"218","volume":"136","author":"ER Paolo Di","year":"2006","unstructured":"Di Paolo ER, Stoetter H, Cotting J, Frey P, Gehri M, Beck-Popovic M, et al. Unlicensed and off-label drug use in a Swiss pediatric university hospital. Swiss Med Wkly. 2006;136:218\u201322.","journal-title":"Swiss Med Wkly"},{"key":"9755_CR31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00228-002-0479-9","volume":"58","author":"GW \u2018t Jong","year":"2002","unstructured":"\u2018t Jong GW, van der Linden PD, Bakker EM, van der Lely N, Eland IA, Stricker BH, van den Anker JN. Unlicensed and off-label use in a pediatric ward of a general hospital in the Netherlands. Eur J Clin Pharmacol. 2002;58:293\u20137.","journal-title":"Eur J Clin Pharmacol"},{"key":"9755_CR32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1542\/peds.111.2.291","volume":"111","author":"E Schirm","year":"2003","unstructured":"Schirm E, Tobi H, Berg LTWJ. Risk factor for unlicensed and off-label drug use in children outside the hospital. Pediatrics. 2003;111:291\u20135.","journal-title":"Pediatrics"},{"key":"9755_CR33","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Brazil). Medicamentos. [Brazilian National Health Surveillance Agency. Drugs]. Available: http:\/\/portal.anvisa.gov.br\/wps\/content\/Anvisa+Portal\/Anvisa\/Inicio\/Medicamentos . Accessed 20 Feb 2011."}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-013-9755-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-013-9755-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-013-9755-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T21:45:17Z","timestamp":1745963117000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-013-9755-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,21]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["9755"],"URL":"https:\/\/doi.org\/10.1007\/s11096-013-9755-2","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"type":"print","value":"2210-7703"},{"type":"electronic","value":"2210-7711"}],"subject":[],"published":{"date-parts":[[2013,2,21]]}}}